Reference health

Selection analysis identifies unusual clustered mutational changes in Omicron lineage BA.1 that likely impact Spike function

https://doi.org/10.1101/2022.01.14.476382
CiteStamped reference-health badge
1 of 55 checkable references need attention · checked 2026-07-22

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

References needing attention

does not resolve to a known work10.1038/d41586-021-03832-5
The 54 checked references that resolve
resolves10.1101/2021.08.20.21262342
Emergence and phenotypic characterization of C.1.2, a globally detected lineage that rapidly accumulated mutations of concern
resolves10.1101/2021.06.03.21258228
Persistent SARS-CoV-2 infection and intra-host evolution in association with advanced HIV infection
resolves10.1101/2021.12.14.472632
Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
resolves10.1101/2022.01.03.21268111
The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism
resolves10.1101/2021.12.31.474653
The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein
resolves10.1101/2021.12.17.473248
SARS-CoV-2 Omicron spike mediated immune escape and tropism shift
resolves10.1101/2021.12.12.472269
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
resolves10.1101/2021.12.28.474380
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
resolves10.1101/2021.05.24.445313
Identification of evolutionary trajectories shared across human betacoronaviruses
resolves10.1002/gch2.1018
Data, disease and diplomacy: GISAID's innovative contribution to global health
resolves10.1093/molbev/msi105
Not So Different After All: A Comparison of Methods for Detecting Amino Acid Sites Under Selection
resolves10.1093/molbev/msz197
HyPhy 2.5—A Customizable Platform for Evolutionary Hypothesis Testing Using Phylogenies
resolves10.1016/j.cell.2021.09.003
The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages
resolves10.1016/J.CHOM.2020.11.007
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
resolves10.1016/j.cell.2020.08.012
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
resolves10.1126/science.abh1139
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
resolves10.1038/s41564-021-00954-4
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
resolves10.1101/2021.04.06.438731
Functional evaluation of the P681H mutation on the proteolytic activation the SARS-CoV-2 variant B.1.1.7 (Alpha) spike
resolves10.1016/j.celrep.2021.109292
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
resolves10.1038/s41586-021-03291-y
SARS-CoV-2 evolution during treatment of chronic infection
resolves10.1126/sciadv.abe5575
Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM
resolves10.1038/s41587-021-01069-1
Ready-to-use public infrastructure for global SARS-CoV-2 monitoring
resolves10.1038/s41586-020-2852-1
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
resolves10.1038/s41586-021-04388-0
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
resolves10.1016/J.CHOM.2021.02.003
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
resolves10.7554/eLife.61312
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
resolves10.1056/NEJMc2031364
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
resolves10.1101/2021.12.19.473380
SARS-CoV-2 Omicron Variant: ACE2 Binding, Cryo-EM Structure of Spike Protein-ACE2 Complex and Antibody Evasion
resolves10.1101/2021.12.16.472934
Neutralization and Stability of SARS-CoV-2 Omicron Variant
resolves10.1101/2021.01.22.427830
Exploring the natural origins of SARS-CoV-2 in the light of recombination
resolves10.1371/journal.pgen.1002764
Detecting Individual Sites Subject to Episodic Diversifying Selection
resolves10.1101/2021.07.17.452804
ACE2 binding is an ancestral and evolvable trait of sarbecoviruses
resolves10.1016/j.cell.2021.07.007
A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation
resolves10.1101/2021.12.23.473975
<i>In vitro</i> evolution predicts emerging CoV-2 mutations with high affinity for ACE2 and cross-species binding
resolves10.1038/s41594-020-0468-7
SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects
resolves10.1038/s41422-020-00430-4
The SARS-CoV-2 spike protein: balancing stability and infectivity
resolves10.1101/2021.12.06.471499
Insights on the mutational landscape of the SARS-CoV-2 Omicron variant
resolves10.1101/2021.12.14.472719
Striking Antibody Evasion Manifested by the Omicron Variant of SARS-CoV-2
resolves10.1371/journal.pcbi.0030231
An Evolutionary-Network Model Reveals Stratified Interactions in the V3 Loop of the HIV-1 Envelope
resolves10.1038/s41467-021-27096-9
Adaptation, spread and transmission of SARS-CoV-2 in farmed minks and associated humans in the Netherlands
resolves10.1038/s41586-021-04353-x
SARS-CoV-2 infection in free-ranging white-tailed deer
resolves10.1101/2021.10.31.466677
Multiple spillovers and onward transmission of SARS-CoV-2 in free-living and captive white-tailed deer
resolves10.1371/journal.ppat.1009849
Acute SARS-CoV-2 infections harbor limited within-host diversity and transmit via tight transmission bottlenecks
resolves10.1016/j.immuni.2017.11.002
HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage
resolves10.1101/2021.12.08.21267417
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
resolves10.1101/2021.12.19.473354
Variable loss of antibody potency against SARS-CoV-2 B.1.1.529 (Omicron)
resolves10.2139/ssrn.3996320
Clinical Severity of COVID-19 Patients Admitted to Hospitals in Gauteng, South Africa During the Omicron-Dominant Fourth Wave
resolves10.1101/2022.01.12.22269148
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa
resolves10.1101/2022.01.03.21268582
Mapping the antigenic diversification of SARS-CoV-2
resolves10.1093/bib/bbx108
MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization
resolves10.1093/bioinformatics/btl474
GARD: a genetic algorithm for recombination detection
resolves10.1093/molbev/msu300
IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-Likelihood Phylogenies
resolves10.1093/molbev/msv035
Gene-Wide Identification of Episodic Selection
resolves10.1371/journal.pbio.3001115
Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen
The 3 references without a DOI — listed, not checked
no DOI — not checkedRambaut, A. et al. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Virological https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563 (2020).
no DOI — not checkedLythgoe, K. A. et al. SARS-CoV-2 within-host diversity and transmission. Science 372, (2021).
no DOI — not checkedArctic Network. SARS-CoV-2 V4.1 update for Omicron variant. https://community.artic.network/t/sars-cov-2-v4-1-update-for-omicron-variant/342.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1101/2022.01.14.476382"><img src="https://citestamp.com/citestamped/10.1101/2022.01.14.476382/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1101/2022.01.14.476382/badge.svg)](https://citestamp.com/citestamped/10.1101/2022.01.14.476382)